TITLE

p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells

AUTHOR(S)
He, Yunlong; de Castro, Luis F.; Shin, Min Hwa; Dubois, Wendy; Yang, Howard H.; Jiang, Shunlin; Mishra, Pravin J.; Ren, Ling; Gou, Hongfeng; Lal, Ashish; Khanna, Chand; Merlino, Glenn; Lee, Maxwell; Robey, Pamela G.; Huang, Jing
PUB. DATE
April 2015
SOURCE
Stem Cells (Wiley-Blackwell);Apr2015, Vol. 33 Issue 4, p1304
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The tumor suppressor, p53, plays a critical role in suppressing osteosarcoma. Bone marrow stromal cells (BMSCs, also known as bone marrow-derived mesenchymal stem cells) have been suggested to give rise to osteosarcomas. However, the role of p53 in BMSCs has not been extensively explored. Here, we report that p53 regulates the lineage choice of mouse BMSCs (mBMSCs). Compared to mBMSCs with wild-type p53, mBMSCs deficient in p53 have enhanced osteogenic differentiation, but with similar adipogenic and chondrogenic differentiation. The role of p53 in inhibiting osteogenic lineage differentiation is mainly through the action of Runx2, a master transcription factor required for the osteogenic differentiation of mBMSCs. We find that p53 indirectly represses the expression of Runx2 by activating the microRNA-34 family, which suppresses the translation of Runx2. Since osteosarcoma may derive from BMSCs, we examined whether p53 has a role in the osteogenic differentiation of osteosarcoma cells and found that osteosarcoma cells with p53 deletion have higher levels of Runx2 and faster osteogenic differentiation than those with wild-type p53. A systems biology approach reveals that p53-deficient mBMSCs are more closely related to human osteosarcoma while mBMSCs with wild-type p53 are similar to normal human BMSCs. In summary, our results indicate that p53 activity can influence cell fate specification of mBMSCs, and provide molecular and cellular insights into the observation that p53 loss is associated with increased osteosarcoma incidence. S tem C ells 2015;33:1304-1319
ACCESSION #
101713525

 

Related Articles

  • The Effect of Cartilage Tissue Extraction of 13 Days-Old Mouse Embryo on Differentiation of Bone Marrow Mesenchymal Stem Cells to Osteoblasts. Ramezani, M.; Khanbabaee, R.; Hojati, V. // Cell Journal (Yakhteh);Summer 2013 Supplement 1, Vol. 15 Issue Sup 1, p71 

    Objective: Mesenchymal stem cells (MSCs) are nonhematopoietic and multipotent cells, which during development are derived from cells with a mesenchymal origin. Also they have high proliferative potential in the long term and are able to differentiation into osteoblast, osteocyte, adipocyte and...

  • Neurogenic induction of human mesenchymal stem cells in fibrin 3D matrix. Shakhbazau, A. V.; Petyovka, N. V.; Kosmacheva, S. M.; Potapnev, M. P. // Bulletin of Experimental Biology & Medicine;Feb2011, Vol. 150 Issue 4, p547 

    We studied the potential of neurogenic induction of human bone marrow mesenchymal stem cells in fibrin-based 3D matrix. The best results were obtained after incubation of mesenchymal stem cells in fibrin 3D matrix in the presence of neurogenic medium containing EGF and bFGF growth factors. Under...

  • A Rare Case of Congenital Erythrocytosis. Meenaloshni, Jayaseelan; Suvarna, Niveditha; Arun, V. // New Indian Journal of Surgery;Jul-Sep2012, Vol. 3 Issue 3, p143 

    Background Erythrocytosis (increased RBC mass or polycythemia) maybe primary due to an intrinsic defect in the bone marrow stem cells/erythroid progenitor cells or secondary where the red cell production is driven by factors external to the erythroid compartment, such as increased erythropoietin...

  • The Heterogeneous HLA Genetic Makeup of the Swiss Population. Buhler, Stéphane; Nunes, José Manuel; Nicoloso, Grazia; Tiercy, Jean-Marie; Sanchez-Mazas, Alicia // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    This study aims at investigating the HLA molecular variation across Switzerland in order to determine possible regional differences, which would be highly relevant to several purposes: optimizing donor recruitment strategies in hematopoietic stem cell transplantation (HSCT), providing reliable...

  • VCAM-1 Expression on Bone Marrow Stromal Cells from Patients with Myelodysplastic Syndromes. Lubkova, O. N.; Tzvetaeva, N. V.; Momotyuk, K. S.; Belkin, V. M.; Manakova, T. E. // Bulletin of Experimental Biology & Medicine;May2011, Vol. 151 Issue 1, p13 

    We studied the expression of VCAM-1 adhesion molecules on stromal cells from the bone marrow of patients with myelodysplastic syndromes, healthy donors, and patients with chronic myeloproliferative diseases and acute leukemias. Expression of adhesion molecule on mesenchymal stromal cells from...

  • Adipocytes Derived from Human Bone Marrow Mesenchymal Stem Cells Exert Inhibitory Effects on Osteoblastogenesis. Zhang, H.; Lu, W.; Zhao, Y.; Rong, P.; Cao, R.; Gu, W.; Xiao, J.; Miao, D.; Lappe, J.; Recker, R.; Xiao, G. G. // Current Molecular Medicine;Aug2011, Vol. 11 Issue 6, p489 

    The infiltration of adipocytes in osteoporotic patients' bone marrow suggests an important regulatory function of bone marrow fat on the development of aged bone. Therefore, we have examined the effects of adipocytes derived from bone mesenchymal stem cell (MSC) on osteoblast differentiation...

  • The Role of Systemically Delivered Bone Marrow-Derived Mesenchymal Stem Cells in the Regeneration of Periodontal Tissues. Meijiao Yu; Shaohua Ge; Fang Wang; Yong Wen; Xinlong Yan; Quan Zeng; Wen Yue; Pishan Yang; Xuetao Pei // Oral & Craniofacial Tissue Engineering;2011, Vol. 1 Issue 4, p331 

    Purpose: Recent studies have shown that periodontal ligament stem cells (PDLSCs) play a key role in periodontal regeneration. However, the origin of these cells remains unclear. Meanwhile, bone marrow is thought to be the most common source of adult stem cells in many tissues and organs. Thus,...

  • CONTROVERSIES RELATED TO CELL CULTURES OBTAINED FROM VARIOUS TISSULAR SAMPLES. Bojin, Florina; Gavriliuc, Oana; Ordodi, Valentin; Cristea, Mirabela; Anghel, Simona; Crisnic, Daniela; Nistor, Daciana; Tatu, Carmen; Tanasie, Gabriela; Panaitescu, Carmen; Paunescu, Virgil // Fiziologia - Physiology;2011, Vol. 21 Issue 4, p4 

    Mesenchymal stern cells (MSCs) are nonhematopoietic stromal cells that are capable of differentiating into, and contribute to the regeneration of, mesenchymal tissues such as bone, cartilage, muscle, ligament, tendon, and adipose. MSCs are identified by the expression of many molecules including...

  • Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Adesida, Adetola B.; Mulet-Sierra, Aillette; Jomha, Nadr M. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 2, p1 

    Introduction: The capacity of bone marrow mesenchymal stromal cells (BMSCs) to be induced into chondrocytes has drawn much attention for cell-based cartilage repair. BMSCs represent a small proportion of cells of the bone marrow stromal compartment and, thus, culture expansion is a necessity for...

Share

Read the Article

Other Topics